Bristol Royal Hospital for Children,
Bristol BS2 8BJ
3 studies enrolling now · 26 studies all time
What they study most
Acute Graft-versus-host Disease, Adenovirus, Adenovirus Infection, Advanced Solid Tumor, Atopic Dermatitis, Cardiac Arrest, Chronic Graft-versus-host-disease, Chronic Kidney Disease, Citrin Deficiency, Congenital Heart Disease, Genetic Obesity, Healthy
Studies at this site
- A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids) — Recruiting now
- A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040) — Recruiting now
- BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies — Recruiting now
- A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD) — Recruiting now
- EMANATE: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway — Completed
- A Study to Assess the Safety, Tolerability, and Efficacy of Rocatinlimab in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) — Completed
- Multi-omics Study in Citrin Deficiency — Running, not enrolling
- A Study of Erdafitinib in Participants With Advanced Solid Tumors and Fibroblast Growth Factor Receptor (FGFR) Gene Alterations — Completed
- Safety and Efficacy of Itacitinib in Combination With Corticosteroids for Treatment of Graft-Versus-Host Disease in Pediatric Subjects — Stopped early
- Open-label Study of Adjunctive GNX Treatment in Children and Adults With TSC-related Epilepsy — Stopped early
- Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy — Completed
- DAYBREAK: A Study of Setmelanotide in Participants With Specific Gene Variants in the Melanocortin-4 Receptor (MC4R) Pathway — Completed
- A Study to Evaluate the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Participants Greater Than or Equal to (>=)1 and Less Than or Equal to (<=) 30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma — Completed
- Posoleucel (ALVR105) for the Treatment of Adenovirus Infection in Pediatric and Adult Participants Receiving Standard of Care Following Allogeneic Hematopoietic Cell Transplantation — Stopped early
- A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1045 (Influenza and Respiratory Syncytial Virus [RSV]) or mRNA-1230 (Influenza, RSV, and Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2]) Vaccine in Adults 50 to 75 Years Old — Completed
- Open-label Extension of Study 20130173 of Denosumab in Children and Young Adults With Osteogenesis Imperfecta — Stopped early
- Lot-to-lot Consistency of Sci-B-Vac™ in Adults — Completed
- The AdAPT Trial; Adenovirus After Allogeneic Pediatric Transplantation — Stopped early
- A Multi-site Randomized Controlled Trial Comparing Regional and General Anesthesia for Effects on Neurodevelopmental Outcome and Apnea in Infants — Completed
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Preliminary Efficacy of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Pediatric and Young Adult Participants With Solid Tumors — Stopped early
- Therapeutic Hypothermia to Improve Survival After Cardiac Arrest in Pediatric Patients-THAPCA-IH [In Hospital] Trial — Completed
- A Study of Subcutaneously Administered Tocilizumab in Participants With Systemic Juvenile Idiopathic Arthritis — Completed
- A Study of Tocilizumab in Patients With Active Polyarticular Juvenile Idiopathic Arthritis — Completed
- A Study of Oral Valcyte (Valganciclovir) in Pediatric Kidney Transplant Recipients — Completed
- Safety and Efficacy of Risedronate in the Treatment of Osteogenesis Imperfecta in Children — Completed
- A Study to Evaluate MEDI-524 In Children With Hemodynamically Significant Congenital Heart Disease — Completed